SCHEMBL10187377

SCHEMBL10187377

Nc1cccc(C(=O)N2Cc3ccccc3C2)c1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TRAP1 Q12931 7/20 0.56
HSP90B1 P14625 5/20 0.56
ALDH1A1 P00352 1/20 0.55
HPGD P15428 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
CA12 O43570 1/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
CA7 P43166 1/20 0.54
CA9 Q16790 1/20 0.54
CA14 Q9ULX7 1/20 0.54
PRMT5 O14744 1/20 0.53
WDR77 Q9BQA1 1/20 0.53
PBRM1 Q86U86 1/20 0.51
HSP90AA1 P07900 5/20 0.51
HSP90AB1 P08238 5/20 0.51
NAMPT P43490 2/20 0.50
MGLL Q99685 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17618301 0.88 TRAP1 (0.65) TRAP1HSP90B1ALDH1A1HPGDSMN1; SMN2
SCHEMBL1947639 0.80 TRAP1 (0.56) TRAP1HSP90B1ALDH1A1HPGDSMN1; SMN2
SCHEMBL12569373 0.80 HPGD (0.64) TRAP1HSP90B1ALDH1A1HPGDSMN1; SMN2
SCHEMBL4167985 0.80 NAMPT (0.64) TRAP1HSP90B1ALDH1A1HPGDSMN1; SMN2
SCHEMBL15271489 0.79 CA12 (0.64) ALDH1A1HPGDSMN1; SMN2CA12CA1
SCHEMBL1877596 0.79 KDM4E (0.68) ALDH1A1HPGDSMN1; SMN2CA12CA1
SCHEMBL520565 0.79 CA12 (0.63) ALDH1A1HPGDCA12CA1CA2
Hydrochloric Acid SCHEMBL7128756 0.78 KDM4E (0.66) ALDH1A1HPGDSMN1; SMN2CA12CA1
SCHEMBL7090972 0.78 HPGD (0.66) ALDH1A1HPGDSMN1; SMN2CA12CA1
Hydrochloric Acid SCHEMBL10437647 0.78 CA12 (0.62) ALDH1A1HPGDCA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012001107-A1 PIPERIDINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-01-05 WO disclosed